Eytan Cohen1,2,3, Yuval Nardi4, Irit Krause5,6, Elad Goldberg7,6, Gai Milo8,6, Moshe Garty9,6, Ilan Krause7,6. 1. Department of Medicine F-Recanati, Rabin Medical Center (Beilinson Campus), 49100, Petah Tikva, Israel. dreytancohen@gmail.com. 2. Clinical Pharmacology Unit, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel. dreytancohen@gmail.com. 3. Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel. dreytancohen@gmail.com. 4. Faculty of Industrial Engineering and Management, Technion-Israel Institute of Technology, Haifa, Israel. 5. Nephrology Institute and Dialysis Unit, Schneider's Children Medical Center of Israel Petah Tikva, Petah Tikva, Israel. 6. Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel. 7. Department of Medicine F-Recanati, Rabin Medical Center (Beilinson Campus), 49100, Petah Tikva, Israel. 8. Nephrology Unit, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel. 9. Recanati Center for Preventive Medicine, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel.
Abstract
BACKGROUND: Cross-sectional studies have long suggested that renal function declines with age. Longitudinal studies regarding this issue are limited. METHODS: We retrospectively analyzed a database of subjects attending a screening center in Israel between the years 2000-2012. Only subjects with normal estimated glomerular filtration rate (eGFR) were included. eGFR was assessed consequently at 5 or more yearly visits. The rate of decline in GFR with age was assessed in healthy subjects and in subjects with comorbidities. RESULTS: The cohort included 2693 healthy subjects and 230 subjects with different comorbidities. Mean (±standard error) annual rate of decline in eGFR in healthy subjects was 0.97 ± 0.02 ml/min/year/1.73 m(2). This decline increased significantly from 0.82 ± 0.22 in age-group 20-30 years to 0.84 ± 0.08, 1.07 ± 0.08 and 1.15 ± 0.12 ml/min/year/1.73 m(2) in age groups 31-40, 41-50 and 50 years and older respectively (p < 0.001). No correlation was found between the annual decline in eGFR and body mass index. In subjects with hypertension, diabetes mellitus, impaired fasting glucose or combined comorbidity the decline in eGFR was 1.12 ± 0.12, 0.77 ± 0.16, 0.85 ± 0.17, and 1.18 ± 0.26 ml/min/year/1.73 m(2) respectively. CONCLUSIONS: This large longitudinal study provides new data on the decrease in eGFR with age. Accurate prediction of the natural rate of GFR decline might be used to distinguish between normally aging kidneys and those with chronic disease. This approach could avoid unnecessary diagnostic procedures in the former and facilitate appropriate treatment in the latter.
BACKGROUND: Cross-sectional studies have long suggested that renal function declines with age. Longitudinal studies regarding this issue are limited. METHODS: We retrospectively analyzed a database of subjects attending a screening center in Israel between the years 2000-2012. Only subjects with normal estimated glomerular filtration rate (eGFR) were included. eGFR was assessed consequently at 5 or more yearly visits. The rate of decline in GFR with age was assessed in healthy subjects and in subjects with comorbidities. RESULTS: The cohort included 2693 healthy subjects and 230 subjects with different comorbidities. Mean (±standard error) annual rate of decline in eGFR in healthy subjects was 0.97 ± 0.02 ml/min/year/1.73 m(2). This decline increased significantly from 0.82 ± 0.22 in age-group 20-30 years to 0.84 ± 0.08, 1.07 ± 0.08 and 1.15 ± 0.12 ml/min/year/1.73 m(2) in age groups 31-40, 41-50 and 50 years and older respectively (p < 0.001). No correlation was found between the annual decline in eGFR and body mass index. In subjects with hypertension, diabetes mellitus, impaired fasting glucose or combined comorbidity the decline in eGFR was 1.12 ± 0.12, 0.77 ± 0.16, 0.85 ± 0.17, and 1.18 ± 0.26 ml/min/year/1.73 m(2) respectively. CONCLUSIONS: This large longitudinal study provides new data on the decrease in eGFR with age. Accurate prediction of the natural rate of GFR decline might be used to distinguish between normally aging kidneys and those with chronic disease. This approach could avoid unnecessary diagnostic procedures in the former and facilitate appropriate treatment in the latter.
Entities:
Keywords:
Estimated GFR; Longitudinal study; Renal function decline
Authors: Ali Mohsen; Rebecca Brown; Richard Hoefield; Philip A Kalra; Donal O'Donoghue; Rachel Middleton; David New Journal: J Nephrol Date: 2012 May-Jun Impact factor: 3.902
Authors: B R Hemmelgarn; J Zhang; B J Manns; M Tonelli; E Larsen; W A Ghali; D A Southern; K McLaughlin; G Mortis; B F Culleton Journal: Kidney Int Date: 2006-03-08 Impact factor: 10.612
Authors: Lawrence J Appel; Jackson T Wright; Tom Greene; John W Kusek; Julia B Lewis; Xuelei Wang; Michael S Lipkowitz; Keith C Norris; George L Bakris; Mahboob Rahman; Gabriel Contreras; Stephen G Rostand; Joel D Kopple; Francis B Gabbai; Gerald I Schulman; Jennifer J Gassman; Jeanne Charleston; Lawrence Y Agodoa Journal: Arch Intern Med Date: 2008-04-28
Authors: C G Musso; C A F Musso; H Joseph; R De Miguel; P Rendo; E Gonzalez; L Algranati; E dos Ramos Farias Journal: Int Urol Nephrol Date: 2004 Impact factor: 2.370
Authors: Matthew R Danzig; Peter Chang; Andrew A Wagner; Mohamad E Allaf; James M McKiernan; Phillip M Pierorazio Journal: Curr Urol Rep Date: 2016-01 Impact factor: 3.092
Authors: Bjørn O Eriksen; Runolfur Palsson; Natalie Ebert; Toralf Melsom; Markus van der Giet; Vilmundur Gudnason; Olafur S Indridason; Lesley A Inker; Trond G Jenssen; Andrew S Levey; Marit D Solbu; Hocine Tighiouart; Elke Schaeffner Journal: J Am Soc Nephrol Date: 2020-06-04 Impact factor: 10.121